| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0008 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.006 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |